David Toung
Stock Analyst at Argus Research
(3.30)
# 1,043
Out of 4,996 analysts
127
Total ratings
63.27%
Success rate
9.5%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Buy | $80 → $90 | $67.21 | +33.91% | 2 | Sep 19, 2025 | |
| MDT Medtronic | Maintains: Buy | $105 → $115 | $94.22 | +22.05% | 7 | Aug 26, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $254.95 | +10.61% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $318.61 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $35.59 | +46.11% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $464.24 | +1.24% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $344.08 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $13.20 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $220.61 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $153.71 | -18.68% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $148.56 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $272.98 | +24.55% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $760.55 | -11.91% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $98.24 | +52.69% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $724.54 | +15.94% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $72.46 | +51.81% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $280.61 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $23.76 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $369.02 | -15.99% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $419.08 | -26.03% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $441.12 | -27.46% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $133.55 | +1.09% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $112.10 | -33.10% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $44.12 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $78.56 | +40.02% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.16 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $51.84 | +136.30% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $73.76 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $123.65 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $179.71 | -13.75% | 4 | Mar 27, 2020 |
Hologic
Sep 19, 2025
Maintains: Buy
Price Target: $80 → $90
Current: $67.21
Upside: +33.91%
Medtronic
Aug 26, 2025
Maintains: Buy
Price Target: $105 → $115
Current: $94.22
Upside: +22.05%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $254.95
Upside: +10.61%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $318.61
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $35.59
Upside: +46.11%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $464.24
Upside: +1.24%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $344.08
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $13.20
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $220.61
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $153.71
Upside: -18.68%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $148.56
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $272.98
Upside: +24.55%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $760.55
Upside: -11.91%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $98.24
Upside: +52.69%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $724.54
Upside: +15.94%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $72.46
Upside: +51.81%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $280.61
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $23.76
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $369.02
Upside: -15.99%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $419.08
Upside: -26.03%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $441.12
Upside: -27.46%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $133.55
Upside: +1.09%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $112.10
Upside: -33.10%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $44.12
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $78.56
Upside: +40.02%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.16
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $51.84
Upside: +136.30%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $73.76
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $123.65
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $179.71
Upside: -13.75%